Our four-gene signature (CDC14A, PDK2, CHAD, and UGT2A3) exemplifies this approach by capturing key aspects of immune homeostasis and epithelial barrier function that are central to IBD pathophysiology. The gene discussed is CDC14A; the disease is inflammatory bowel disease.